XNYS · Diagnostics & Research
Last stored close · Nov 10, 2026
Close · Nov 10, 2026
$475.52-0.25%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
56/100
Positive
Score components
TickerWhale View
Waters scores 56 out of 100 overall, which we rate positive. Technical is its strongest area and Valuation its weakest.
What helps
- Technical
- Quality & growth
- Risk
What to watch
- Valuation
Quality & growth
30%60Positive
- Revenue growth 52.5%
- EPS growth -63.9%
Valuation
25%16Weak
- P/E 281.1
- EV/Sales 11.0
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
#262 by market cap in our coverage · ~7,900 employees · Listed 1995-11-17 · www.waters.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
#69 / 139sector rank by TickerWhale Score
TickerWhale Score 56 vs sector average 54.6 (+1.4)
Revenue growth (industry)Top 5%
Gross margin (industry)Top 65%
Return on equity (industry)Top 76%
P/E (industry)Pricier than 93%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
91/100Strong vs universe
Ranks 91st of 100 covered names on our technical composite — the composite itself scores 81/100 · 25% of the TickerWhale Score
Classic chart indicators
Buy
5 buy · 2 sell · 1 neutral of 8 votes
TickerWhale rates WAT's technical setup strong — 91st percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.
Moving averages
9 / 9constructive
- vs 200-day+27.8%
- vs 50-day+8.8%
Momentum
Mixed
- RSI (14)61 · neutral
- Stochasticsell
- CCIbuy
- Williams %Rsell
Trend
Constructive
- ADX (14) trend strength34· trending
- MACD (12,26,9)buy(histogram 0.195)
How the classic verdict is reached
Moving averages (9) agree on buy — 9 buy vs 0 sell — and carry one vote between them.
Oscillators (7) vote individually: 4 buy · 2 sell · 1 neutral.
Result — 5 buy vs 2 sell of 8 votes = Buy. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-11-10 · revised_latestValuation multiples
- P/E (TTM)281.1
- P/S (TTM)10.1
- P/B3.1
- EV/EBITDA—
- EV/Sales11.0
- PEG—
Profitability & returns
- Gross margin50.9%
- Net margin3.6%
- ROE1.1%
- Debt/Equity0.33
Growth
- Revenue growth (YoY)52.5%
- EPS growth (YoY)-63.9%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $46.7B
Fundamentals history
Reported statement totals across recent periods.
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: KNSA →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WATCurrentWaters | 56 | 81 | 281.1 | — | 3.1 | 11.0 | $475.52 | -0.25% | +52.5% | ||
| EXELExelixis | 82 | 88 | 21.3 | — | 9.9 | 7.4 | $70.58 | -1.62% | +9.2% | ||
| KNSAKiniksa Pharmaceuticals International plc. - | 79 | 81 | 98.2 | — | 12.1 | 9.3 | $95.02 | -3.79% | +58.9% | ||
| THCTenet Healthcare | 79 | 81 | 10.9 | — | 5.2 | 1.6 | $290.27 | +0.44% | +7.5% | ||
| INCYIncyte | 76 | 67 | 15.5 | — | 3.9 | 3.6 | $120.30 | -1.30% | +26.9% | ||
| LIVNLivaNova | 76 | 84 | 27.2 | — | 3.9 | 3.3 | $91.14 | -1.59% | +12.4% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.